The Clinical Trials Information System (CTIS) was launched on 31 January 2022, starting the clock for the three-year transition period from the Clinical Trials Directive to the Clinical Trials Regulation. Since 31 January 2023, it is mandatory for sponsors to submit all initial clinical trial applications via CTIS. In less than a year, from 31 January 2025 onwards sponsors will need to comply with their obligations under the CTR and its Delegated Acts.
The European Medicines Agency (EMA) is organising this open event to provide:
This EMA-hosted webinar is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations.
To continue reading this article please go to EMA .